Eagle Pharmaceuticals Stock Market Value
| EGRX Stock | USD 0.34 0.36 51.43% |
| Symbol | Eagle |
Eagle Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eagle Pharmaceuticals. If investors know Eagle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eagle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share 0.1 | Revenue Per Share | Quarterly Revenue Growth (0.13) | Return On Assets |
The market value of Eagle Pharmaceuticals is measured differently than its book value, which is the value of Eagle that is recorded on the company's balance sheet. Investors also form their own opinion of Eagle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eagle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eagle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eagle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eagle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eagle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eagle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Eagle Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eagle Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eagle Pharmaceuticals.
| 01/14/2025 |
| 01/09/2026 |
If you would invest 0.00 in Eagle Pharmaceuticals on January 14, 2025 and sell it all today you would earn a total of 0.00 from holding Eagle Pharmaceuticals or generate 0.0% return on investment in Eagle Pharmaceuticals over 360 days. Eagle Pharmaceuticals is related to or competes with Medicure, and Eco Growth. Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to t... More
Eagle Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eagle Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eagle Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 33.79 | |||
| Information Ratio | 0.0237 | |||
| Maximum Drawdown | 180.7 | |||
| Value At Risk | (37.60) | |||
| Potential Upside | 46.67 |
Eagle Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eagle Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eagle Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Eagle Pharmaceuticals historical prices to predict the future Eagle Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0296 | |||
| Jensen Alpha | 0.1236 | |||
| Total Risk Alpha | (1.97) | |||
| Sortino Ratio | 0.0188 | |||
| Treynor Ratio | 0.0895 |
Eagle Pharmaceuticals Backtested Returns
Eagle Pharmaceuticals is abnormally volatile given 3 months investment horizon. Eagle Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0604, which denotes the company had a 0.0604 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.65% are justified by taking the suggested risk. Use Eagle Pharmaceuticals Downside Deviation of 33.79, coefficient of variation of 3731.39, and Mean Deviation of 13.46 to evaluate company specific risk that cannot be diversified away. Eagle Pharmaceuticals holds a performance score of 4 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 7.94, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Eagle Pharmaceuticals will likely underperform. Use Eagle Pharmaceuticals total risk alpha, as well as the relationship between the downside variance and rate of daily change , to analyze future returns on Eagle Pharmaceuticals.
Auto-correlation | -0.88 |
Excellent reverse predictability
Eagle Pharmaceuticals has excellent reverse predictability. Overlapping area represents the amount of predictability between Eagle Pharmaceuticals time series from 14th of January 2025 to 13th of July 2025 and 13th of July 2025 to 9th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eagle Pharmaceuticals price movement. The serial correlation of -0.88 indicates that approximately 88.0% of current Eagle Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.88 | |
| Spearman Rank Test | -0.88 | |
| Residual Average | 0.0 | |
| Price Variance | 1.66 |
Eagle Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Eagle Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eagle Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Eagle Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Eagle Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eagle Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eagle Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eagle Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eagle Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Eagle Pharmaceuticals Lagged Returns
When evaluating Eagle Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eagle Pharmaceuticals stock have on its future price. Eagle Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eagle Pharmaceuticals autocorrelation shows the relationship between Eagle Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Eagle Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eagle Stock Analysis
When running Eagle Pharmaceuticals' price analysis, check to measure Eagle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eagle Pharmaceuticals is operating at the current time. Most of Eagle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eagle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eagle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eagle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.